PHAXIAM Therapeutics S.A.

PHXM · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$10,474$38,789$33,699$44,446
Short-Term Investments$0$43$479$8
Receivables$4,864$2,576$4,709$4,334
Inventory$0$1,268$0$0
Other Curr. Assets$881-$42$1,640$852
Total Curr. Assets$16,219$42,634$40,048$49,632
Property Plant & Equip (Net)$3,899$2,977$25,829$29,090
Goodwill$9,622$0$0$0
Intangibles$0$5$15$589
Long-Term Investments$0$0$7$17
Tax Assets$0$0$0$0
Other NC Assets$21,567$195$869$1,074
Total NC Assets$35,088$3,177$26,720$30,770
Other Assets$0$0$0$0
Total Assets$51,307$45,811$66,768$80,402
Liabilities
Payables$3,679$1,562$2,485$4,706
Short-Term Debt$3,887$3,340$1,981$3,872
Tax Payable$0$0$3,716$4,149
Deferred Revenue$0$51$93$148
Other Curr. Liab.$7,698$6,725$11,730$16,472
Total Curr. Liab.$15,264$11,678$20,005$29,347
LT Debt$7,030$10,227$23,394$23,576
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,401$420$524$940
Total NC Liab.$10,431$10,647$23,918$24,516
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$25,695$22,325$43,923$53,863
Equity
Pref Stock$0$0$0$0
Common Stock$6,075$3,102$3,102$2,006
Retained Earnings$0-$228-$53,797-$73,300
AOCI-$30,134-$28,363-$24,078-$22,872
Other Equity$49,671$48,975$97,618$120,705
Total Equity$25,612$23,486$22,845$26,539
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$51,307$45,811$66,768$80,402
Net Debt$443-$25,222-$8,324-$16,998